Dactolisib outperforms Rapamycin in potentiating apoptosis induced by XPO1, Bcl-2 and Mcl-1 blockade in preclinical glioblastoma models.
Overview & Synopsis
Open access biomedical research article published in FEBS Open Bio.
Indexed from repository: PubMed Central
(
pmc.ncbi.nlm.nih.gov)
Keyboard Shortcuts:
← / → for pages • + / - for zoom • 0 to fit width
Powered by Mozilla PDF.js v3.11
Document Information
| Document Title | Dactolisib outperforms Rapamycin in potentiating apoptosis induced by XPO1, Bcl-2 and Mcl-1 blockade in preclinical glioblastoma models. |
|---|---|
| Author / Organization | Zhao K, Meyer L, Braun M, Otte K, Bitter C, Pawlik M, Raifer H, Helmprobst F, Pagenstecher A, Urban H, Burger MC, Ronellenfitsch MW, Steinbach JP, Jedelská J, Bagheri S, Yousefi BH, Di Fazio P, Luster M, Mahnken AH, Neubauer A, Burchert A, Nimsky C, Bartsch JW, Rusch T |
| Subject & Discipline | FEBS Open Bio |
| Categories | Medicine & Health |
| Publication Year | 2026 |
| License / Rights | Open Access / Creative Commons |
| Resource Verification | Listed PDF (Verification Pending) |
| Original Host Website |
PubMed Central
(pmc.ncbi.nlm.nih.gov)
|
| File Format | application/pdf (Portable Document Format) |
| Language | EN |
| Catalog ID | DOC-12581 |
| Original Source Link | Visit Source Page on pmc.ncbi.nlm.nih.gov » |